Activist investor ValueAct takes $600m stake in Japan’s Olympus

Planned changes to corporate governance requirements embolden foreign funds
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals